Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03702907 · ClinicalTrials.gov registry record
DC Longitudinal Study on Aging and Specimen Bank
A clinical trial of Alzheimer Disease and Aging, sponsored by Georgetown University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03702907 is a study of Alzheimer Disease and Aging that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 1,000 participants, below the 2,747-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03702907, a study of Alzheimer Disease and Aging, is actively recruiting participants, sponsored by Georgetown University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal changes in biological, lifestyle, and cognitive assessment collection. The primary goal of this study is to examine the feasibility of biochemical assays, genetic testing, and cognitive and lifestyle assessments in the ante-mortem diagnosis of Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. This research involves genetic and cognitive status testing but the findings will not be shared with research subjects. This will be accomplished ex vivo using blood, and/or cerebrospinal fluid (CSF) specimens from patients with a diagnosis of probable Alzheimer's disease, mild cognitive impairment, or other neurodegenerative diseases and from normal controls.
Conditions Studied
Study Locations (1)
District of Columbia
- Georgetown University Memory Disorders Program - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2007-01-01 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03702907
The ClinicalTrials.gov registry entry for NCT03702907 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,747-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (64% lower). The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03702907 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03702907 about?
NCT03702907 is a clinical study titled "DC Longitudinal Study on Aging and Specimen Bank". The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal c...
What is the current status of trial NCT03702907?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2007-01-01. Estimated completion is 2027-01.
What conditions does trial NCT03702907 study?
This clinical trial studies the following conditions: Alzheimer Disease, Aging, Mild Cognitive Impairment, Dementia, Aging Disorder.
Who is sponsoring clinical trial NCT03702907?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03702907 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
RECRUITING · Phase 3
-
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
RECRUITING · Phase 4
-
Systemic and Central Inflammation in AD
RECRUITING · Phase 2
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
RECRUITING · Phase 1
-
Cognitive Neurology Unit Clinical Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.